BIOSKETCHES FOR DCM-NMP PEER REVIEW PANELISTS 

Dr. Gary Ginsberg (Chair) is a toxicologist at the Connecticut Department of Public Health 

within the Division of Environmental and Occupational Health Assessment. He has 

responsibility for human health risk assessments conducted within the state government. Dr. 

Ginsberg serves as adjunct faculty at the Yale School of Public Health and is an Assistant 

Clinical Professor at the University of Connecticut School of Community Medicine. He is 

currently a member of the National Academy of Sciences committee reviewing inorganic arsenic 

and served on two previous NAS committees (Human Biomonitoring, 2007; USEPA Risk 

Methods which produced Science and Decisions, 2009). He was first author of a manuscript that 

won best paper of the year award from the Society of Toxicology Risk Assessment Specialty 

Section, 2009. Dr. Ginsberg was a member of USEPA’s Children’s Health Protection Advisory 

Committee until 2009 and is currently a member of USEPA’s Science Advisory Board. He has 

participated on expert review panels for state governments in Minnesota, New Jersey, California 

and Massachusetts. He was an Oak Ridge Institute for Science and Education (ORISE) fellow 

with USEPA’s National Center for Environmental Assessment from 2010 to 2012. He has 

published in the areas of early life stage vulnerability, pharmacokinetic modeling, genetic 

polymorphisms, metabolism in aging populations, fish consumption advisories and 

environmental risk assessment. Dr. Ginsberg's toxicology experience has involved a variety of 

settings: basic research, teaching, working within the pesticide and consulting industries, and 

now working in public health. Dr. Ginsberg is also co-author of a book on toxics for the lay 

public, “What’s Toxic, What’s Not:” Berkley Books, December 2006.

Dr. Thomas W. Armstrong is the Principal Investigator since 2008 at his sole proprietor 

consulting company, TWA8HR Occupational Hygiene Consulting, LLC. Dr. Armstrong 

received his B.A. in Chemistry, M.S. in Environmental Health, and Ph.D. in Environmental 

Engineering, all from Drexel University in Philadelphia, Pennsylvania. He currently has an 

Adjunct Professor appointment at the Drexel University School of Public Health. Before he 

retired from ExxonMobil Biomedical Sciences in 2008, his last position there was as Senior 

Scientific Associate in Exposure Sciences. While at ExxonMobil, he developed exposure 

assessment strategies for and provided support to multiple epidemiology studies, including work 

under contract to the University of Colorado to support multiple general population 

epidemiology investigations in Shanghai, China. Also, while at ExxonMobil, Dr. Armstrong 

served on the company’s internal occupational exposure limit committee and published a method 

for adjusting exposure limits to extended work schedules. His ongoing research activities include 

exposure assessment for epidemiology studies, mathematical methods to estimate exposures to 

chemicals and quantitative risk assessments for Legionella and Legionnaires’ disease. He has 30 

peer reviewed publications, has contributed multiple chapters to three books and has provided 

peer reviews to eight journals. Dr. Armstrong has presented on diverse topics at symposia in the 

United States and abroad. He was the lead instructor for American Industrial Hygiene 

Association (AIHA) professional development courses on mathematical modeling to assess 

chemical exposures, and Monte Carlo Simulation techniques in exposure assessment, and has 

taught in other courses, including a review of toxicology for industrial hygienists. He remains 

active in AIHA risk assessment, epidemiology and exposure assessment committee activities. 

Dr. Armstrong was a member of two National Academy of Sciences committees that conducted 

reviews of and completed reports on risk assessments for two national biocontainment 
laboratories. In addition, he provided support to a National Institute for Occupational Safety and 

Health (NIOSH) review of the institute’s occupational exposure assessment strategy, and served 

on a NIOSH National Occupational Research Agenda committee. He also participated in several 

panels on EPA children’s health issues. 

Dr. Frank A. Barile is Professor of Applied and Clinical Toxicology in the Department of 

Pharmaceutical Sciences, St. John's University College of Pharmacy and Health Sciences, New 

York. He received his Ph.D. in Toxicology (1982) at St. John's University. He completed postdoctoral fellowships at the Albert Einstein College of Medicine, Bronx, NY, and Columbia 

University, NY. In 1984, he was appointed Assistant Professor in the Department of Health 

Sciences at City University of NY. Sixteen years later he rejoined St. John's University in the 

Department of Pharmaceutical Sciences. Dr. Barile holds memberships in the U.S. Society of 

Toxicology, the American Association for the Advancement of Science, and the New York 

Academy of Sciences. He was elected President of the In Vitro & Alternative Methods Specialty 

Section of the U.S. Society of Toxicology (2005-2008) and was recently elected VP-elect for the 

Dermal Toxicology Specialty Section (2013-2014), followed by President. He is the recipient of 

the U.S. Public Health Service Medallion from the Director of the NIEHS, Dr. Linda Birnbaum 

(June, 2009). Dr. Barile is the recipient of PHS research grants from the National Institutes of 

Health (NIGMS) for the last 20 years, as well as from the Alternative Research & Development 

Foundation (Jenkinton, PA) and the International Foundation for Ethical Research (Chicago, IL). 

Dr. Barile has authored approximately 75 papers and abstracts in peer-reviewed biomedical and 

toxicology journals, as well as five books and three chapters, including Clinical Toxicology: 

Principles and Mechanisms, 2nd edition, 2010 (Informa HealthCare, UK) and Principles of 

Toxicology Testing, 2nd edition, 2013 (CRC Press, FL). Recently published articles describe the 

development of in vitro ocular toxicity testing methods for detecting irritant and corrosive 

properties of chemicals (J. Pharmacological Toxicological Methods, 2010) and highlight 

epigenetic mechanisms using trace metals in embryonic stem cells (Toxicology Letters, 2012). 

Dr. Barile serves on the editorial boards of Toxicology In Vitro (2007-present) and J. 

Pharmacological & Toxicological Methods (2008-present). He is currently Editor-in-Chief of 

Toxicology In Vitro (2012-present). He continues fundamental research on the cytotoxic effects 

of environmental chemicals on cultured human and mammalian embryonic stem cells.

Dr. James V. Bruckner is currently Professor of Pharmacology and Toxicology in the 

Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy of the University 

of Georgia (UGA). He organized and directed the UGA Interdisciplinary Toxicology Graduate 

Program in Toxicology for 15 years. Prior to that time he held a tenured faculty position at the 

University of Texas Medical School at Houston. He received his B.S. degree in pharmacy and 

M.S. degree in toxicology from the University of Texas in Austin. His Ph.D. in toxicology was 

awarded by the University of Michigan. Dr. Bruckner's primary areas of expertise are general 

toxicology, toxicokinetics (TK) and human health risk assessment. His primary research focus is 

on the toxicology and TK of volatile organic chemical contaminants of drinking water, drugchemical interactions at environmental exposure levels, metabolic and toxicokinetic bases for 

susceptibility of children to chemicals, and physiological modeling of solvents and pyrethroid 

insecticides. The relevance of experimental designs to health risks of "real life" chemical 

exposures is of particular interest. Research funding for the past 35 years has consistently come 

from federal agencies for toxicology studies of problems of national concern. The primary 
funding sources have been the U.S. EPA, DOE, CDC and Air Force. Dr. Bruckner has published 

more than 200 journal articles, book chapters and abstracts. Many of these papers focus on the 

toxicology, TK and PBPK modeling. He has served on a variety of expert panels and 

committees for the U.S. EPA, NIEHS, NASA, Air Force, ATSDR/CDC,FDA and National 

Academy of Sciences (NAS). The NAS appointments have included, among others, the 

Committees on Safe Drinking Water, Pesticides in Diets and Infants and Children; Acute 

Exposure Guideline Levels; Health and Safety Consequences of Child Labor; Use of Third Party 

Pesticide Toxicity Research with Human Participants; and Contaminated Drinking Water at 

Camp Lejeune. Such work has frequently involved assessment of health risks to populations 

living in the proximity of military chemical and nuclear disposal sites (e.g., Camp Lejeune, NC; 

Fort Detrick, MD; Savannah River site, SC). Dr. Bruckner is currently a member of the ACGIH 

TLV chemical substances panel and the NAS Committee on Toxicology.

Dr. Anneclaire J. De Roos is Associate Professor of Environmental and Occupational Health in 

the Drexel University School of Public Health in Philadelphia, PA. She earned a B.A. 

(Geography/Ecosystems) from the University of California at Los Angeles, MPH 

(Epidemiology/Biostatistics) from the University of California at Berkeley, and a Ph.D. 

(Epidemiology) in the year 2000 from the University of North Carolina at Chapel Hill. Her 

research interests and experience are primarily in the study of occupational and environmental 

exposures to chemicals and radiation as risk factors for cancer, autoimmune diseases and 

intermediate biologic effects. Dr. De Roos’ dissertation research focused on parental 

occupational exposures as risk factors for childhood cancer in their offspring. From 2000–2002, 

Dr. De Roos trained as a postdoctoral fellow in the Division of Cancer Epidemiology and 

Genetics of the National Cancer Institute (NCI), where she gained experience in studies of 

genetic determinants of disease and intermediate biologic effects (immune function, 

inflammation) of environmental exposures. She was a member of the faculty at the University of 

Washington (UW) and Fred Hutchinson Cancer Research Center in Seattle, WA from 2003–

2012, where her research focused on environmental risk factors for non-Hodgkin lymphoma, 

leukemias and other cancers, including: workplace exposures (pesticides, solvents); persistent 

organic pollutants (PCBs, dioxins); and point sources of pollution (industrial facilities, traffic). 

Dr. De Roos has been a member of the International Lymphoma Epidemiology (InterLymph) 

Consortium since 2005, and currently is funded by the National Institute of Environmental 

Health Sciences (NIEHS) to conduct a consortium-based evaluation of occupational solvent 

exposure as a potential cause of multiple myeloma. At the UW, Dr. De Roos taught courses in 

cancer epidemiology, environmental and occupational epidemiology, public health in the media, 

and advanced epidemiologic methods. In her current position at Drexel, Dr. De Roos is 

developing a new masters’ level course in environmental risk assessment. She serves as a 

frequent reviewer for occupational and environmental health journals, most notably as an 

editorial review board member for Environmental Health Perspectives. She has published more 

than 90 refereed research articles, authored 7 book chapters, and made numerous invited 

presentations at national and international conferences. Dr. De Roos also has served on several 

expert committees in recent years, including those reviewing formaldehyde for NIEHS’s Report 

on Carcinogens and the trichloroethylene (TCE) health assessment document for the USEPA.
Dr. Annette Guiseppi-Elie is a Principal Consultant on Exposure and Risk Assessment issues 

for the DuPont Company. Also, she is an Adjunct Associate Professor in Environmental 

Engineering and Earth Sciences at Clemson University. She is a Fellow of the American 

Institute of Medical and Biological Engineers. She has served on a number of scientific entities 

in her role as technical expert and advocate for the use of sound scientific principles and data in 

conducting environmental health risk assessments. These organizations include the USEPA 

Science Advisory Board, the Mickey Leland Center National Urban Air Toxics Research Center, 

the International Programme on Chemical Safety’s Planning Committee on Harmonization of 

Exposure Assessment, and the American Chemistry Council’s Strategic Science Team, where 

she currently leads the Exposure Subcommittee. She is past Chair of the American Industrial 

Heath Council’s Environmental Health Risk Assessment Committee. Her expertise is in the areas 

of site and risk assessment, specifically, exposure assessments and includes environmental fate 

and transport processes. Dr. Guiseppi-Elie has conducted environmental site assessments and 

risk assessments both in the US and internationally. Her doctoral research focused on the fate 

and transport of dioxins in the environment. Her current research interests are in the areas of 

integrated/cumulative exposure (including exposomics) and risk assessment and the relationship 

between indoor, outdoor and personal air exposures. Her work experience includes service on the 

faculty at Drexel University, service to Mobil Oil and the Exxon Corporation. Dr. Guiseppi-Elie 

received the B.Sc. degree in Chemistry and Zoology and the M.Sc. in Crop Production 

Entomology from the University of the West Indies (UWI), Trinidad in 1977 and 1979, 

respectively. She received a M.Sc. degree in Pollution and Environmental Control from the 

University of Manchester Institute of Science and Technology (UMIST), England in 1980 and 

her Ph.D. in Civil Engineering from the University of Maryland College Park (UMCP), USA in 

1987. 

Dr. Ronald D. Hood is Principal of Ronald D. Hood and Associates, Toxicology Consultants. 

He also is Professor Emeritus of Biological Sciences, having retired from the faculty of the Cell, 

Molecular, and Developmental Biology Section of the Department of Biological Sciences of the 

University of Alabama after 32 years of service, and he has been an Adjunct Professor of Public 

Health, School of Public Health, University of Alabama at Birmingham. Dr. Hood received his 

Ph.D. from Purdue University in 1969 in Reproductive Physiology and joined the faculty of the 

University of Alabama as an Assistant Professor. He was promoted to the rank of Professor by 

1978, and he also served as Interim Department Chair from July 1996 to August, 1997. In 

addition, Dr. Hood was Consultant in Environmental Medicine for the U.S. Veterans 

Administration, Office of Medicine and Surgery, Agent Orange Special Projects Office (off site), 

during 1983, and a Special Consultant, Science Advisory Board, EPA, from 1983 through 1993. 

He has served as a consultant to pharmaceutical, chemical, and biotech companies, trade 

associations, federal and state regulatory agencies, and law firms since 1978. Dr. Hood presented 

toxicology training courses to regulatory personnel of Health Canada annually from 2006 to 

2011. Dr. Hood has served as a member of the editorial boards of Fundamental and Applied 

Toxicology and Toxicological Sciences, and he was an ad hoc member of EPA’s Food Quality 

Protection Act Science Review Board. Dr. Hood has participated in workshops and expert panels 

to provide expertise on developmental toxicity and risk assessment, and he was inducted as a 

Fellow of the Academy of Toxicological Sciences. Dr. Hood has authored, coauthored or edited 

more than 100 publications (research articles, book chapters and books) in the areas of 

developmental and reproductive toxicology. Dr. Hood’s most recent edited book is 
Developmental and Reproductive Toxicology, a Practical Approach, Third Edition, published in 

2012, by the Informa Healthcare division of CRC Press. Dr. Hood has been active in the 

Teratology Society, chairing the Membership, Education, Constitution/Bylaws, and Website 

committees. He also has been active in the Reproductive and Developmental Toxicology 

Specialty Section of the Society of Toxicology, and he has served as their newsletter editor.

Dr. John C. Kissel is currently Professor of Environmental and Occupational Health Sciences at 

the University of Washington in Seattle, where he has been a member of the faculty since 1990. 

He held a prior position in the School of Public and Environmental Affairs at Indiana University. 

Dr. Kissel holds a Ph.D. in Civil/Environmental Engineering from Stanford University and is a 

registered professional engineer. Dr. Kissel's research interests generally involve human 

exposure assessment, with emphasis on exposures related to waste management, agricultural and 

residential use of pesticides, and consumer products. He is particularly interested in probabilistic 

prediction of aggregate exposure and reconciliation of model predictions with observed 

biomarker data. Dr. Kissel and his students have produced multiple papers describing human 

exposure to soil that are listed as “key studies” in US EPA’s Exposure Factors Handbook. Dr. 

Kissel is a former President and Councilor of the International Society of Exposure Science and 

also served one term as chair of the Exposure Assessment Specialty Group within the Society for 

Risk Analysis. He was a member of a National Academy of Sciences Committee that evaluated 

Superfund-related remediation of mining and smelting related contamination in the Coeur 

d’Alene Basin in Idaho and a reviewer of the WHO environmental health criteria document on 

Dermal Exposure, which will be published soon. Dr. Kissel has served as an ad hoc member of 

US EPA's FIFRA Science Advisory Panel on multiple occasions and is currently a member of 

EPA’s Human Studies Review Board. His recent research activities have been funded by US 

EPA, US DOE, NIOSH and the Washington State Departments of Ecology and Health. 

Dr. Philip J. Lupo is an epidemiologist and Assistant Professor of Pediatrics in the Section of 

Hematology-Oncology at Baylor College of Medicine. He earned his BS degree from Houston 

Baptist University, Houston, Texas (Biology and Political Science); his MPH from University of 

Texas School of Public Health (Disease Control); and his PhD degree from University of Texas 

School of Public Health (Epidemiology). His doctoral research was focused on the association 

between hazardous air pollutants and birth defects, as well as epidemiologic methods related to 

these studies (e.g., exposure misclassification due to residential mobility and etiologic 

heterogeneity among composite phenotypes). This research has led to several published 

manuscripts and ongoing collaborations with investigators at the Texas Birth Defects Registry 

and other birth defects surveillance systems. For his post-doctoral training, Dr. Lupo served as a 

Faculty Associate in the Human Genetics Center at University of Texas School of Public Health 

in order to gain additional training in the design and analysis of family-based association studies 

(case-parent triads) to assess not only inherited genetic effects, but also novel genetic 

mechanisms such as maternally-mediated genetic effects, genomic imprinting, and geneenvironment interactions. Dr. Lupo has developed an expertise in genetic and environmental 

determinants of birth defects and childhood cancer. Dr. Lupo also serves as an Associate 

Member of the Texas Center for Birth Defects Research and Prevention. Aside from being a 

funded collaborator with the Centers for Disease Control-funded National Birth Defects 

Prevention Study, Dr. Lupo is the recipient of the American Heart Association’s Beginning 

Grant-in-Aid to evaluate prenatal exposure to environmental toxicants and the risk of congenital 
heart defects. Dr. Lupo has also recently received a grant from the National Institutes of Health 

to explore the role of air toxics and neighborhood environment on the risk of oral clefts. 

Additionally, Dr. Lupo is currently collaborating with other researchers and clinicians to develop 

studies examining the role of genes and prenatal exposures on the development of childhood 

cancer, as well as the identification of novel risk factors for long-term complications of 

childhood cancer therapies. As a member of the Children’s Oncology Group (COG) 

Epidemiology Committee, Dr. Lupo is working with investigators to build a research program in 

the epidemiology of rhabdomyosarcoma. He serves as a member of the American Heart 

Association’s Genomics & Translational Epidemiology & Observational Epidemiology 

Population Science 2 Peer Review Committee and has been a reviewer for 21 journals. He has 

published 45 refereed publications, authored 3 book chapters, and made several invited speeches 

and presentations at national and international conferences.

Dr. Ernest E. McConnell D.V.M., M.S. (Path), DACVP, DABT is the president of ToxPath, 

Inc., a private consulting firm in Raleigh, North Carolina. He received his D.V.M. from The 

Ohio State University, an M.S. in Pathology from Michigan State University, and completed a 

residency in comparative pathology at the Armed Forces Institute of Pathology, Walter-Reed 

Army Medical Center. He spent 13 years in the U.S. Air Force and 14 in the US Public Health 

Service. Gene's positions in the government included an assignment at the Veterinary Research 

Institute, Onderstepoort, South Africa, Aerospace Medical Research Lab., Wright-Patterson Air 

Force Base, Ohio and National Institute of Environmental Health Sciences (NIEHS), where he 

was Chief of the Chemical Pathology Branch and Director of the National Toxicology Program’s 

(NTP) Division of Toxicology Research and Testing. At NTP, he was instrumental in the design 

of the classic NTP bioassays; acute, subchronic and chronic, which are today considered the 

“Gold Standard.” After leaving the NTP, Dr. McConnell continued to be involved in NTP-type 

bioassays, and over his career he has been directly involved in more than 300 chronic bioassays 

and is still active in this regard today. He is a diplomate of the American College of Veterinary 

Pathologists and the American Board of Toxicology, of which he is a past president. He has been 

a member of numerous national and international forums dealing with toxicology and pathology, 

including the National Academy of Sciences, Chair of the EPA Science Advisory Panel, panel 

member on the International Agency for Research on Cancer monographs and various panels of 

the World Health Organization. He is the author of more than 300 peer-reviewed publications. 

His research has focused on the design and interpretation of rodent bioassays of various 

toxicants, especially the pathology caused by various types of natural and man-made fibers. 

Dr. Stephen B. Pruett is Professor of Immunotoxicology and Head of the Department of Basic 

Sciences at the College of Veterinary Medicine, Mississippi State University. He earned his B.S. 

degree from Northwestern State University of Louisiana (Microbiology) and his Ph.D. degree 

from Louisiana State University School of Medicine in Shreveport (Immunology). He had postdoctoral training at the University of Alabama of Birmingham School of Medicine 

(Immunology) with Dr. J. Claude Bennett, and received training in toxicology and pharmacology 

during a Sabbatical with Dr. Albert E. Munson at the Medical College of Virginia. Dr. Pruett 

began his academic research career as an assistant professor in the Department of Biological 

Sciences at Mississippi State University and left at the rank of professor after 13 years to take a 

similar position at the LSU Health Sciences Center in Shreveport. He returned to Mississippi 

State University in his current position after 10 years at LSU. His research interests include the 
effects of drugs, chemicals, and stress on the immune system. He has a long interest in 

pesticides, drugs of abuse, and psychological stressors and has been funded by the National 

Institutes of Health (NIH) for work in each of these areas. He is currently a member of the Innate 

Immunity and Inflammation Study Section for NIH and has served as a frequent ad hoc grant 

reviewer for several other NIH study sections beginning in 1990. He serves on the editorial 

boards of two leading toxicology journals, Toxicological Sciences and Toxicology and Applied 

Pharmacology, and recently served several years as an Associate Editor for the Journal of 

Immunology. He has served in several leadership positions in the Society of Toxicology, 

including President of the South Central Chapter and President of the Immunotoxicology 

Specialty Section. He is a Fellow of the Academy of Toxicological Sciences and a member of 

the American College of Toxicologists. He has published more than 115 peer-reviewed 

manuscripts and 10 book chapters, and has been an invited speaker at numerous meetings in the 

U.S., Australia, Europe, and Japan.

Dr. Pamela Williams is co-founder of E Risk Sciences, LLP, a small, women-owned business 

whose mission is to provide sound scientific analyses and tools to support risk-based decisionmaking related to human health and the environment. She is also a Clinical Assistant Professor 

in the Department of Environmental and Occupational Health at the Colorado School of Public 

Health, and a Fellow with the non-profit organization Toxicology Excellence for Risk 

Assessment (TERA). Dr. Williams earned her B.A. from San Diego State University, San 

Diego, California (Sociology, Program in Applied Social Research); her M.S. from Harvard 

University, Boston, Massachusetts (Health and Social Behavior); and her ScD from Harvard 

University, Boston, Massachusetts (Environmental Health and Health Policy & Management). 

From 2007 to 2009 she worked as a Senior Science and Science Policy Advisor in the Office of 

Research and Development at the U.S. Environmental Protection Agency. Prior that time, she 

worked as a Principal Health Scientist at ChemRisk (2003–2007), Senior Scientist at Exponent 

(1999–2003), Research Analyst at the Harvard Center for Risk Analysis (1996–1999), Scientist 

at Environmental Health and Engineering (1997), Intern at the Agency for Toxic Substances and 

Disease Registry (1995), and Research Associate at Social Impact Assessment (1993–1994). Dr. 

Williams specializes in assessing human exposures and health risks in environmental, 

community, and occupational settings. She has published over 100 papers, book chapters, and 

presentation abstracts on such topics. She has served as a technical peer reviewer for a number 

of journals and has peer-reviewed screening-level chemical assessments prepared by Health 

Canada. She also served on the n-Alkanes peer consultation panel under EPA’s Voluntary 

Children’s Chemical Evaluation Program. Dr. Williams currently serves as the Chair of the Risk 

Assessment Committee at the American Industrial Hygiene Association, and formerly served on 

the Board of Directors at the Society for Risk Analysis (2003-2007). She was the 2007 recipient 

of the Joan M. Daisey Outstanding Young Scientist Award, granted by the International Society 

of Exposure Science in recognition of outstanding contribution to the science of human exposure 

analysis by a young scientist, and the 2009 recipient of the Chauncey Starr Distinguished Award, 

granted by the Society for Risk Analysis in recognition of excellent contributions to the field of 

Risk Analysis. She was named a Fellow of the Society for Risk Analysis in 2012.